Compared with IMRT alone, the combination of IMRT and MWD more effectively downregulates tumor markers and the levels of TGF-β, bEGF, and HMGA1 in patients with cervical cancer, improves tumor control effectiveness and patient QoL, and facilitates the improvement of disease prognosis. This evidence concerns the gene HMGA1 and cervical carcinoma.